Department of Pathology, Hubei Cancer Hospital, Wuhan, Hubei, China.
Department of Pathology, Hubei Cancer Hospital, Wuhan, Hubei, China.
Oral Surg Oral Med Oral Pathol Oral Radiol. 2023 Sep;136(3):e116-e122. doi: 10.1016/j.oooo.2023.04.007. Epub 2023 Apr 15.
We report our diagnosis of a rare case of primary angiomatoid fibrous histiocytoma in the mandible of a 42-year-old male using next-generation sequencing to detect disease-specific EWSR1-ATF1 fusion.
After the initial cone beam computerized tomography scan and reconstruction, we performed immunohistochemical staining and fluorescence in situ hybridization analysis on tissue samples to detect EWSR1 gene rearrangement. For the final diagnosis, we performed next-generation sequencing to detect disease-specific EWSR1-ATF1 fusion.
FISH analysis showed approximately 55% of tumor cells with mostly isolated red signals, as well as several split red-green signals, indicating the presence of EWSR1 gene rearrangement. Next-generation sequencing analysis identified an EWSR1 exon9-ATF1 exon4 fusion, a diagnostic biomarker of angiomatoid fibrous histiocytoma (AFH). Based on the findings, we diagnosed primary AFH derived from the mandible.
Next-generation sequencing is a powerful methodology for detecting disease-specific EWSR1-ATF1 fusion and diagnosing primary angiomatoid fibrous histiocytoma.
我们通过下一代测序检测疾病特异性 EWSR1-ATF1 融合,报告了一例 42 岁男性下颌部原发性血管肌纤维母细胞瘤的罕见病例。
在初始锥形束计算机断层扫描和重建后,我们对组织样本进行免疫组织化学染色和荧光原位杂交分析,以检测 EWSR1 基因重排。为了最终诊断,我们进行了下一代测序以检测疾病特异性 EWSR1-ATF1 融合。
FISH 分析显示约 55%的肿瘤细胞具有大多数孤立的红色信号,以及几个分裂的红绿信号,表明存在 EWSR1 基因重排。下一代测序分析鉴定出 EWSR1 外显子 9-ATF1 外显子 4 融合,这是血管肌纤维母细胞瘤(AFH)的诊断生物标志物。基于这些发现,我们诊断为源自下颌的原发性 AFH。
下一代测序是一种强大的方法,可用于检测疾病特异性 EWSR1-ATF1 融合并诊断原发性血管肌纤维母细胞瘤。